glp 1 hyperthyroidism GLP-1 Receptor Agonists Explained for Pharmacy & Medical Students: Mechanism, Uses, and Side Effects hyperthyroidism | The American Journal
Description
As GEP-44 advances through IND-enabling studies and toward eventual phase I trials, SureNano Science represents one of the relatively few microcap public companies providing direct exposure to the rapidly expanding GLP-1 market
FDA approvals for obesity indications have substantially expanded the addressable patient population beyond diabetes, creating unprecedented commercial opportunities
Elevated leptin levels activate signaling pathways (JAK/STAT, MAPK, and PI3K/Akt) that support cancer cell proliferation, angiogenesis, and metastasis
180-day exclusivity is valuable but fragile
